Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q2 2026)
- 58,868
- Value
- $29.5M
- % of portfolio
- 1.3%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 58,868 | $29.5M | 1.3% | −530−0.9% | Reduced | Holders |
| Q1 2026 | 59,398 | $29.2M | 1.5% | +671+1.1% | Added | Holders |
| Q4 2025 | 58,727 | $34.0M | 1.7% | −119−0.2% | Reduced | Holders |
| Q3 2025 | 58,846 | $28.5M | 1.5% | +1,771+3.1% | Added | Holders |
| Q2 2025 | 57,075 | $23.1M | 1.3% | +1,415+2.5% | Added | Holders |
| Q1 2025 | 55,660 | $27.7M | 1.8% | +6,989+14.4% | Added | Holders |
| Q4 2024 | 48,671 | $25.3M | 1.6% | +5,954+13.9% | Added | Holders |
| Q3 2024 | 42,717 | $26.4M | 1.7% | +1,134+2.7% | Added | Holders |
| Q2 2024 | 41,583 | $23.0M | 1.7% | +2,240+5.7% | Added | Holders |
| Q1 2024 | 39,343 | $22.9M | 1.8% | −11,494−22.6% | Reduced | Holders |
| Q4 2023 | 50,837 | $27.0M | 1.7% | +1,774+3.6% | Added | Holders |
| Q3 2023 | 49,063 | $24.8M | 1.8% | +1,285+2.7% | Added | Holders |
| Q2 2023 | 47,778 | $24.9M | 1.8% | +658+1.4% | Added | Holders |
| Q1 2023 | 47,120 | $27.2M | 2.2% | +1,186+2.6% | Added | Holders |
| Q4 2022 | 45,934 | $25.3M | 2.2% | +216+0.5% | Added | Holders |
| Q3 2022 | 45,718 | $23.2M | 2.2% | +366+0.8% | Added | Holders |
| Q2 2022 | 45,352 | $24.6M | 2.1% | +1,724+4.0% | Added | Holders |
| Q1 2022 | 43,628 | $25.8M | 1.9% | +556+1.3% | Added | Holders |
| Q4 2021 | 43,072 | $28.7M | 2.0% | +356+0.8% | Added | Holders |
| Q3 2021 | 42,716 | $24.4M | 1.9% | +581+1.4% | Added | Holders |
| Q2 2021 | 42,135 | $21.3M | 1.7% | +1,158+2.8% | Added | Holders |
| Q1 2021 | 40,977 | $18.7M | 1.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.